These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
349 related articles for article (PubMed ID: 10527637)
1. Inhibition of histone deacetylation augments dihydrotestosterone induction of androgen receptor levels: an explanation for trichostatin A effects on androgen-induced chromatin remodeling and transcription of the mouse mammary tumor virus promoter. List HJ; Smith CL; Rodriguez O; Danielsen M; Riegel AT Exp Cell Res; 1999 Nov; 252(2):471-8. PubMed ID: 10527637 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of MMTV transcription by HDAC inhibitors occurs independent of changes in chromatin remodeling and increased histone acetylation. Mulholland NM; Soeth E; Smith CL Oncogene; 2003 Jul; 22(31):4807-18. PubMed ID: 12894222 [TBL] [Abstract][Full Text] [Related]
3. Effects of antiandrogens on chromatin remodeling and transcription of the integrated mouse mammary tumor virus promoter. List HJ; Smith CL; Martinez E; Harris VK; Danielsen M; Riegel AT Exp Cell Res; 2000 Oct; 260(1):160-5. PubMed ID: 11010820 [TBL] [Abstract][Full Text] [Related]
4. Comparison of chromatin remodeling and transcriptional activation of the mouse mammary tumor virus promoter by the androgen and glucocorticoid receptor. List HJ; Lozano C; Lu J; Danielsen M; Wellstein A; Riegel AT Exp Cell Res; 1999 Aug; 250(2):414-22. PubMed ID: 10413595 [TBL] [Abstract][Full Text] [Related]
5. Histone acetylation characterizes chromatin presetting by NF1 and Oct1 and enhances glucocorticoid receptor binding to the MMTV promoter. Astrand C; Belikov S; Wrange O Exp Cell Res; 2009 Sep; 315(15):2604-15. PubMed ID: 19463811 [TBL] [Abstract][Full Text] [Related]
6. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription. Zhang Y; Fatima N; Dufau ML Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786 [TBL] [Abstract][Full Text] [Related]
7. Transcriptional silencing of the mouse mammary tumor virus promoter through chromatin remodeling is concomitant with histone H1 phosphorylation and histone H3 hyperphosphorylation at M phase. Bhattacharjee RN; Archer TK Virology; 2006 Mar; 346(1):1-6. PubMed ID: 16458342 [TBL] [Abstract][Full Text] [Related]
8. Trichostatin A reduces hormone-induced transcription of the MMTV promoter and has pleiotropic effects on its chromatin structure. Astrand C; Klenka T; Wrange O; Belikov S Eur J Biochem; 2004 Mar; 271(6):1153-62. PubMed ID: 15009194 [TBL] [Abstract][Full Text] [Related]
9. Identification of glucocorticoid receptor domains necessary for transcriptional activation of the mouse mammary tumor virus promoter integrated in the genome. Bonovich MT; List HJ; Zhang S; Danielsen M; Riegel AT Exp Cell Res; 1998 Mar; 239(2):454-62. PubMed ID: 9521864 [TBL] [Abstract][Full Text] [Related]
10. Prolonged glucocorticoid exposure dephosphorylates histone H1 and inactivates the MMTV promoter. Lee HL; Archer TK EMBO J; 1998 Mar; 17(5):1454-66. PubMed ID: 9482742 [TBL] [Abstract][Full Text] [Related]
11. The histone deacetylase inhibitor trichostatin A blocks progesterone receptor-mediated transactivation of the mouse mammary tumor virus promoter in vivo. Wilson MA; Ricci AR; Deroo BJ; Archer TK J Biol Chem; 2002 Apr; 277(17):15171-81. PubMed ID: 11821430 [TBL] [Abstract][Full Text] [Related]
12. Chromatin remodeling and control of cell proliferation by progestins via cross talk of progesterone receptor with the estrogen receptors and kinase signaling pathways. Vicent GP; Ballaré C; Zaurin R; Saragüeta P; Beato M Ann N Y Acad Sci; 2006 Nov; 1089():59-72. PubMed ID: 17261755 [TBL] [Abstract][Full Text] [Related]
13. Histone H1 enhances synergistic activation of the MMTV promoter in chromatin. Koop R; Di Croce L; Beato M EMBO J; 2003 Feb; 22(3):588-99. PubMed ID: 12554659 [TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation. Law AY; Lai KP; Lui WC; Wan HT; Wong CK Exp Cell Res; 2008 Oct; 314(16):2975-84. PubMed ID: 18652825 [TBL] [Abstract][Full Text] [Related]
15. FR901228, a potent antitumor antibiotic, is a novel histone deacetylase inhibitor. Nakajima H; Kim YB; Terano H; Yoshida M; Horinouchi S Exp Cell Res; 1998 May; 241(1):126-33. PubMed ID: 9633520 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of histone deacetylase activity causes cell type-specific induction of the PDGF-B promoter only in the absence of activation by its enhancer. Ullerås E; Miller SJ; Adam GI; Kanduri C; Wilcock AC; Franklin GC Exp Cell Res; 2001 Nov; 270(2):188-98. PubMed ID: 11640883 [TBL] [Abstract][Full Text] [Related]
17. Histone modification in the TGFbetaRII gene promoter and its significance for responsiveness to HDAC inhibitor in lung cancer cell lines. Osada H; Tatematsu Y; Sugito N; Horio Y; Takahashi T Mol Carcinog; 2005 Dec; 44(4):233-41. PubMed ID: 16163707 [TBL] [Abstract][Full Text] [Related]
18. The mouse mammary tumour virus promoter positioned on a tetramer of histones H3 and H4 binds nuclear factor 1 and OTF1. Spangenberg C; Eisfeld K; Stünkel W; Luger K; Flaus A; Richmond TJ; Truss M; Beato M J Mol Biol; 1998 May; 278(4):725-39. PubMed ID: 9614938 [TBL] [Abstract][Full Text] [Related]
19. The histone deacetylase inhibitor trichostatin A downregulates human MDR1 (ABCB1) gene expression by a transcription-dependent mechanism in a drug-resistant small cell lung carcinoma cell line model. El-Khoury V; Breuzard G; Fourré N; Dufer J Br J Cancer; 2007 Aug; 97(4):562-73. PubMed ID: 17667922 [TBL] [Abstract][Full Text] [Related]
20. Moderate increase in histone acetylation activates the mouse mammary tumor virus promoter and remodels its nucleosome structure. Bartsch J; Truss M; Bode J; Beato M Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10741-6. PubMed ID: 8855250 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]